HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Zymergen (ZY) Investors to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations
The firm is investigating possible securities law violations and certain investors may have valuable claims.
- The firm is investigating possible securities law violations and certain investors may have valuable claims.
- More specifically, Zymergen said it does not expect any product revenues in 2021 and that 2022 revenues would be immaterial.
- Were focused on investors losses and whether Zymergen lied about Hyalines business prospects, said Reed Kathrein, the Hagens Berman partner leading the investigation.
- Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.